SEGMENT RESULTS- Schedule of Depreciation Expenses (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Segment Reporting Information
Total depreciation expense	$ 50,515	$ 54,318	$ 84,191
Operating Segments | Branded Pharmaceuticals
Segment Reporting Information
Total depreciation expense	9,252	9,862	10,632
Operating Segments | Sterile Injectables
Segment Reporting Information
Total depreciation expense	22,652	20,224	17,796
Operating Segments | Generic Pharmaceuticals
Segment Reporting Information
Total depreciation expense	11,829	16,952	47,343
Operating Segments | International Pharmaceuticals
Segment Reporting Information
Total depreciation expense	3,561	3,638	4,242
Corporate unallocated
Segment Reporting Information
Total depreciation expense	$ 3,221	$ 3,642	$ 4,178